Comparing and combining biomarkers as principal surrogates for time-to-event clinical endpoints
- 28 October 2014
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 34 (3) , 381-395
Abstract
Principal surrogate endpoints are useful as targets for phase I and II trials. In many recent trials, multiple post‐randomization biomarkers are measured. However, few statistical methods exist for comparison of or combination of biomarkers as principal surrogates, and none of these methods to our knowledge utilize time‐to‐event clinical endpoint information. We propose a Weibull model extension of the semi‐parametric estimated maximum likelihood method that allows for the inclusion of multiple biomarkers in the same risk model as multivariate candidate principal surrogates. We propose several methods for comparing candidate principal surrogates and evaluating multivariate principal surrogates. These include the time‐dependent and surrogate‐dependent true and false positive fraction, the time‐dependent and the integrated standardized total gain, and the cumulative distribution function of the risk difference. We illustrate the operating characteristics of our proposed methods in simulations and outline how these statistics can be used to evaluate and compare candidate principal surrogates. We use these methods to investigate candidate surrogates in the Diabetes Control and Complications Trial. Copyright © 2014 John Wiley & Sons, Ltd.Keywords
This publication has 20 references indexed in Scilit:
- Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacyBiostatistics, 2013
- Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine TrialsBiometrics, 2013
- A Bayesian Approach to Improved Estimation of Causal Effect Predictiveness for a Principal Surrogate EndpointBiometrics, 2012
- Comparing Biomarkers as Principal Surrogate EndpointsBiometrics, 2011
- Statistical Identifiability and the Surrogate Endpoint Problem, with Application to Vaccine TrialsBiometrics, 2010
- A Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical TrialsBiometrics, 2010
- Evaluating Candidate Principal Surrogate EndpointsBiometrics, 2008
- Augmented Designs to Assess Immune Response in Vaccine TrialsBiometrics, 2006
- Counterfactual Links to the Proportion of Treatment Effect Explained by a Surrogate MarkerBiometrics, 2005
- Principal Stratification in Causal InferenceBiometrics, 2002